Fox Run Management’s ARS Pharmaceuticals SPRY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-22,992
Closed -$154K 978
2023
Q2
$154K Buy
+22,992
New +$154K 0.04% 610